(Source: IBA - International Bar Association) Proposed Pfizer deal suggests tax inversions will continue, despite US plans to stop 'corporate deserters' Jonathan Watson Late last year, US pharmaceutical giant Pfizer agreed a deal to acquire the company Allergan for $160bn. If approved by regulators, it should be completed in the second half of 2016 - and be the biggest ever acquisition in the sector. It's also one of the most controversial. If the deal goes through, it would enable New York-based Pfizer to move its headquarters to Ireland where Allergan is based, and benefit from a much lower rate of corporate tax. The new combined entity could cut its tax rate from around 25 per cent for...
Legal and business news from the IBA - February/March 2016 (IBA - International Bar Association) ...
↧
↧
Trending Articles
More Pages to Explore .....